Medipharm Labs Corp T.LABS

So when LABS CEO stated they have over 20 'strong' clinical

[subaru1i]

trials, many in late stage then you have to ask yourself where are they all being conducted?  We already know the "who"...with their 'large traditional global phamaceutical partner' and NOT by coincidence, Pfizer hooked up with USC way back in 2013 for new 'innovative' solutions including cancer.   That 2013 hook up between Pfizer and USC...where the LABS Libby study is being conducted, the timing of 2013 hooks up to having over 20 strong clincial trials, many in LATE STAGE.....ie PHASE 3.

[okgonow]

a year ago...............tgere are cobwebs on that NR

[QContinuum1]

Trials don't progress to the next phase with pixie dust...results must be publicized and the records accessible via the clinical trials site. If there are no PHIII trials listed on the site, then there are none that LABS are associated with from the list they provided.  Stating otherwise is lying.

[mdjbrown]

It certainly doesnt happen over night, but the LiBBY Trial has promise with both the FDA and DEA on board. Not to mention the $16 million award from NIH to Keck Treatment of Alzheimer’s Agitation Disorder         Phase 2 Recent Milestone: "FDA approval of Investigational New Drug (IND) Clinical trial material (CTM) delivered and enrollment commencing in Q3 2023